![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 5-((1-(6-(trifluoromethyl)-1h-benzo(d)imidazol-2-yl)-1a,6b-dihydro-1h-cyclopropa(b)benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyrdin-2(1h)-one
2. Bgb-283
3. Lifrafenib
1. Lifirafenib
2. Bgb-283
3. 1446090-77-2
4. 1446090-79-4
5. Bgb283
6. Lifirafenib [usan]
7. 5-(((1r,1as,6br)-1-(6-(trifluoromethyl)-1h-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1h-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1h)-one
8. Bgb 283
9. 8762xzs5zf
10. 5-(((1r,1as,6br)-1-(6-(trifluoromethyl)-1h-benzimidazol-2-yl)-1a,6b-dihydro-1h-cyclopropa(b)benzofuran-5-yl)oxy)-3,4-dihydro-1h-1,8-naphthyridin-2-one
11. 5-[[(1r,1as,6br)-1-[6-(trifluoromethyl)-1h-benzimidazol-2-yl]-1a,6b-dihydro-1h-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1h-1,8-naphthyridin-2-one
12. 1,8-naphthyridin-2(1h)-one, 5-(((1r,1as,6br)-1a,6b-dihydro-1-(6-(trifluoromethyl)-1h-benzimidazol-2-yl)-1h-cyclopropa(b)benzofuran-5-yl)oxy)-3,4-dihydro-
13. 5-({(1r,1as,6br)-1-[5-(trifluoromethyl)-1h-benzimidazol-2-yl]-1a,6b-dihydro-1h-cyclopropa[b][1]benzofuran-5-yl}oxy)-3,4-dihydro-1,8-naphthyridin-2(1h)-one
14. Compound 2.2b
15. 5-{{(1r,1as,6br)-1-[5-(trifluoromethyl)-1h-benzimidazol-2-yl]-1a,6b-dihydro-1h-cyclopropa[b][1]benzofuran-5-yl}oxy}-3,4-dihydro-1,8-naphthyridin-2(1h)-one
16. Lifirafenib [inn]
17. Lifirafenib (usan/inn)
18. Unii-8762xzs5zf
19. Bgb-283;beigene-283
20. Lifirafenib [who-dd]
21. Gtpl8958
22. Chembl4209157
23. Schembl15085288
24. Bdbm372968
25. Ex-a1473
26. Us9895376, Compound 2.2b
27. Whc09077
28. Whc09079
29. Lifirafenib;bgb-283;beigene-283
30. Bdbm50453816
31. Who 10554
32. Zinc68764621
33. Cs-6308
34. Db14773
35. Ac-35880
36. Ac-36373
37. Hy-18957
38. D11410
39. A900647
40. Q27075193
41. 3k3
Molecular Weight | 478.4 g/mol |
---|---|
Molecular Formula | C25H17F3N4O3 |
XLogP3 | 3.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 3 |
Exact Mass | 478.12527490 g/mol |
Monoisotopic Mass | 478.12527490 g/mol |
Topological Polar Surface Area | 89.1 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 845 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |